[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100260086":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":15,"locations":23,"responsibleParty":59,"collaborators":62,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":76,"sex":77,"minAge":78,"maxAge":7,"enrollmentInfo":79,"targetDuration":7,"studyType":82,"phases":7,"briefSummary":83,"conditions":84,"keywords":89,"overallStatus":26,"whyStopped":7,"lastUpdateSubmitDate":98,"lastUpdatePostDateStruct":99,"startDateStruct":102,"completionDateStruct":104,"leadSponsor":106,"locationsCount":107},{"fullName":5,"class":6},"MaineHealth","OTHER",null,[9,13],{"name":10,"affiliation":11,"role":12},"Sergey Ryzhov, MD, PhD","MaineHealth Institute for Research","PRINCIPAL_INVESTIGATOR",{"name":14,"affiliation":5,"role":12},"David B Seder, MD",[16,20],{"name":14,"role":17,"phone":18,"phoneExt":7,"email":19},"CONTACT","207-662-2179","david.seder@mainehealth.org",{"name":21,"role":17,"phone":7,"phoneExt":7,"email":22},"Sergey Ryzhov, PhD","sergey.ryzhov@mainehealth.org",[24],{"facility":25,"status":26,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Maine Medical Center","RECRUITING","Portland","Maine","04102","United States","US",{"type":33,"coordinates":34},"Point",[35,36],-70.2589,43.65737,{"lat":36,"lon":35},[39,40,42,45,46,47,49,51,53,55,57],{"name":14,"role":17,"phone":18,"phoneExt":7,"email":19},{"name":10,"role":17,"phone":7,"phoneExt":7,"email":41},"Sergey.ryzhov@mainehealth.org",{"name":43,"role":44,"phone":7,"phoneExt":7,"email":7},"David J Gagnon, PharmD","SUB_INVESTIGATOR",{"name":14,"role":12,"phone":7,"phoneExt":7,"email":7},{"name":10,"role":12,"phone":7,"phoneExt":7,"email":7},{"name":48,"role":44,"phone":7,"phoneExt":7,"email":7},"Teresa May, DO",{"name":50,"role":44,"phone":7,"phoneExt":7,"email":7},"Richard Riker, MD",{"name":52,"role":44,"phone":7,"phoneExt":7,"email":7},"Angela M Leclerc, PA-C",{"name":54,"role":44,"phone":7,"phoneExt":7,"email":7},"Brittany Lachance, DO",{"name":56,"role":44,"phone":7,"phoneExt":7,"email":7},"Patrick T Mailloux, DO",{"name":58,"role":44,"phone":7,"phoneExt":7,"email":7},"Matthew Lynes, PhD",{"type":12,"investigatorFullName":60,"investigatorTitle":61,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"David B. Seder MD","Chair, Department of Critical Care Services",[63,66],{"name":64,"class":65},"National Institute of General Medical Sciences (NIGMS)","NIH",{"name":67,"class":65},"National Heart, Lung, and Blood Institute (NHLBI)","100260086","immunoinflammatory-response-in-post-cardiac-arrest-syndrome-pcas-100260086",false,"NCT02664831","Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)","Immunoinflammatory and Metabolic Responses in Post Cardiac Arrest Syndrome (PCAS)","PCAS","Inclusion Criteria:\n\n* Aged 18 years or older\n* Admitted to the intensive care unit after cardiac arrest episode\n* Unresponsive after resuscitation\n\nExclusion Criteria:\n\n* Moribund \u002F actively dying at the time of evaluation\n* Informed consent cannot be obtained within 24 hours of resuscitation\n* Hemoglobin less than 7.0 g\u002FdL, active high-volume bleeding, or requiring a transfusion",true,"ALL","18 Years",{"count":80,"type":81},400,"ESTIMATED","OBSERVATIONAL","This is a prospective, observational study to investigate molecular mechanisms mediating the systemic inflammatory process, and changes to metabolism, and their impact on brain injury, survival, and functional outcomes after cardiac arrest. Investigators have shown that cardiac arrest induces changes in the numbers and properties of circulating immune cells, shifting the balance towards a pro-inflammatory phenotype and there is increased interest in the inflammatory pathways and the signaling mechanisms through which they are modulated. Participants will undergo blood sampling during 7 days following cardiac arrest, and analyses performed. Patient characteristics, clinical circumstances, and outcomes will be recorded and their associations with these inflammatory pathways characterized.",[85,86,87,88],"Cardiac Arrest","Inflammation","Obesity","Hypoxic Ischemic Encephalopathy (HIE)",[90,91,92,93,94,95,96,97],"cardiac arrest","inflammation","immune","neuregulin","lymphocyte","neutrophil","brown adipose","HIE","2025-07-15",{"date":100,"type":101},"2025-07-18","ACTUAL",{"date":103,"type":101},"2016-01",{"date":105,"type":81},"2028-01",{"name":5,"class":6},1]